GlassScriptPhysician profile
Kara Nan Ferrell
NPI 1982075396
$4,303.30
in general payments reported to CMS, 2019-2025
16 companies · $694 in 2025
The $694 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $559 · 2022: $1,011 · 2023: $1,054 · 2024: $985 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,733.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,755.48 | 2021-2025 | |
| Gilead Sciences, INC. | $1,042.20 | 2021-2025 | Epclusa, Biktarvy |
| Insmed, INC. | $263.21 | 2021-2025 | Arikayce |
| Viiv Healthcare Company | $260.28 | 2021-2025 | Dovato, Apretude, Cabenuva |
| Merck Sharp & Dohme LLC | $178.69 | 2021-2024 | Dificid, Pifeltro, Recarbrio |
| Astellas Pharma US INC | $167.77 | 2021-2022 | |
| Cumberland Pharmaceuticals, INC. | $143.15 | 2021-2023 | Vibativ |
| Paratek Pharmaceuticals, INC. | $128.65 | 2022-2025 | Nuzyra |
| Ferring Pharmaceuticals INC. | $85.03 | 2022-2023 | Rebyota |
| Shionogi INC | $70.05 | 2022-2024 | Fetroja |
| Emd Serono, INC. | $65.36 | 2024-2025 | |
| Nestle Healthcare Nutrition INC. | $44.60 | 2023 | |
| Melinta Therapeutics, LLC | $35.64 | 2025 | Orbactiv, Rezzayo |
| Janssen Biotech, INC. | $32.85 | 2022 | |
| Aimmune Therapeutics, INC. | $17.50 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.84 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Ferrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.